Navigation Links


wave in Biological Technology

Polycystic Kidney Disease Assay at Cornell University Uses Transgenomic's Surveyor Nuclease & WAVE Technology

OMAHA, Neb., April 2 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO). In a peer-reviewed paper published in the February 2009 issue of the journal Human Mutation, a team at Weill Cornell Medical College New York describes in detail the key advantages of using Transgenomic'...

Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc.

BEDFORD, Mass., July 24 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX ) today announced the successful completion of the tender offer by its direct wholly-owned subsidiary, Thunder Tech Corp., for all outstanding shares of Third Wave Technologies, Inc. (Nasdaq: TWTI ) at a price of $...

Hologic, Inc. Accepts Shares of Third Wave Technologies, Inc. in Tender Offer and Commences Subsequent Offering Period

BEDFORD, Mass. and MADISON, Wis., July 17 /PRNewswire-FirstCall/ -- Hologic, Inc. (Nasdaq: HOLX ) and Third Wave Technologies, Inc. (Nasdaq: TWTI) ("Third Wave"), today jointly announced the expiration of the initial offering period of the tender offer by its wholly-owned subsidiary Thunder T...

ORNL super water repellent could cause big wave in market

OAK RIDGE, Tenn., Nov. 29, 2007 -- A water repellent developed by researchers at the Department of Energys Oak Ridge National Laboratory outperforms nature at its best and could open a floodgate of commercial possibilities. The super-water repellent (superhydrophobic) material, developed by Joh...

'Radio wave cooling' offers new twist on laser cooling

Visible and ultraviolet laser light has been used for years to cool trapped atomsand more recently larger objectsby reducing the extent of their thermal motion. Now, applying a different form of radiation for a similar purpose, physicists at the National Institute of Standards and Technology (NIST...

Device Computing: The Wave Is Building

Editor's Note: The following is an excerpt from Chris Shipley's keynote at DEMOmobile 2003, held September 17-19, 2003, Hilton La Jolla Torrey Pines, La Jolla, California. For the complete text, go to: http://www.idgef.com/demomobile/images03/DEMOmobile_shipley.pdf . This is an amazing time t...

Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan

MADISON, Wis. -- Third Wave Technologies Inc. (Nasdaq: TWTI) today announced it delivered a total of 200,000 single nucleotide polymorphism (SNP) assays to RIKEN in Japan for use in various large scale genotyping projects. Since the beginning of 2003, Third Wave has been supplying its Invader ...

Third Wave Releases Gene Test

Madison, Wis. -- Third Wave Technologies Inc , a maker of molecular diagnostic products, recently announced the release of its Invader 2D6 analysis panel, which provides clinical trial laboratories with access to a broad range of pharmacogenetic assays available for the important 2D6 gene. The ...

Third Wave Broadens Market, Releases Genetic Technology to Early Adopters

Madison, Wis. -- Third Wave Technologies Inc. announced Tuesday that its genetic analysis Invader technology platform has been successfully extended to chromosomal analysis, opening a new market to the company. In conjunction with this important extension of the Invader technology, Madison-ba...

Wisconsin-based Third Wave reports increased revenue for 2003, fourth quarter

MADISON - Third Wave Technologies Inc. , a Madison-based provider of molecular diagnostics, reported fourth quarter and year-end earnings for 2003 last Tuesday. The year was transitional for Third Wave as the company focused its research, marketing and financial resources away from the genomic too...

Third Wave strikes deal with Kaiser Permanente on cystic fibrosis reagents

MADISON - Third Wave Technologies has announced the launch of its Invader cystic fibrosis genotyping analyte-specific reagents. In conjunction with Invaders premiere, the company announced a new partnership with Kaiser Permanente , the largest non-profit health plan in the United States, to sup...

Third Wave releases reagents for Hepatitis C testing

MADISON - Third Wave Technologies announced a new line of genotyping reagents for the Hepatitis C virus Monday at the 20th Annual Clinical Virology Symposium in Florida. The Hepatitis C virus is the leading cause of liver disease in the United States and affects 4 million Americans, leading to...

Third Wave lands European distribution deal, reports high earnings

MADISON Third Wave Technologies Inc. and Innogenetics NV announced Tuesday a four-year marketing and distribution agreement. Under the terms of the agreement, Third Wave has granted Belgium-based Innogenetics the exclusive European marketing and distribution rights for select Invader molecular...

Third Wave continues molecular diagnostic focus with new CEO

MADISON Third Wave Technologies Inc. announced Thursday that its co-founder, Lance Fors , is transitioning to the position of executive chairman in order to focus on the assessment and development of next-generation technologies. In addition, the company announced that John J. Puisis , Third W...

Third Wave to buy back stock

MADISON Third Wave Technologies announced Tuesday that it will repurchase up to 5% of its outstanding stock. The board of directors approved purchases on the open market or in private transactions in a show of confidence in the company's potential. "Third Wave's stock repurchase program unders...

Third Wave and 3M couple biotech technologies

MADISON, Wis. Third Wave Technologies and 3M announced Wednesday the signing of a supply agreement that will provide Third Wave customers with the option of coupling its Invader technology, a DNA and RNA analysis chemistry, with 3M's microfluidic technology. Under the agreement, 3M Bioanalyti...

Southwestern lab selects Third Wave reagents for Hepatitis tests

MADISON, Wis. Third Wave Technologies Inc. has announced that the southwestern laboratory network TriCore Reference Laboratories has adopted Third Wave's Invader Hepatitis C Virus genotyping reagents. The reagents are part of tests that can identify all six types of the Hepatitis C virus, a...

Third Wave files patent infringement suit against Stratagene

Red blood cells, some of which are affected by sickle-cell anemia. Source: National Institutes of Health. MADISON, Wis. Third Wave Technologies , a Madison-based provider of genetic diagnostic tools, announced Wednesday afternoon that it has sued the California-based Stratagene Corp. to defe...

Third Wave to seek FDA clearences after expanding pipeline

Madison, Wis. Third Wave Technologies has expanded its product pipeline and will seek FDA clearance for several products within the next few years, the company told investors and analysts on Thursday. Third Wave, based in Madison, makes molecular genetic diagnostics. The company said revenu...

Third Wave boosts numbers in latest report

Madison, Wis. Third Wave Technologies this week reported the best annual financial results in the company's short history, wrapping up a year in which it met or exceeded all of its stated fiscal expectations. Third Wave reported total revenues of $46.5 million and a net loss of $1.9 million...

WARF honored nationally; Wingra Technologies aquired; Third Wave financials up

In this week's Tech Update, by WTN's Mike Klein: The Wisconsin Alumni Research Foundation will receive a medal of honor from the president for its contributions to technology transfer. Wingra Technologies has been acquired by a west-coast software firm. And biotech company Third Wave Technolog...

Third Wave co-founder shoots for small target in latest project

Madison, Wis. Researchers led by James Dahlberg, a founder of Madison-based bioscience company Third Wave Technologies , have found that a super-small genetic element may play a critical role in the development of certain types of cancer. Teams led by Dahlberg and collaborator Wayne Tam at t...

Third Wave reports down quarter, which CEO calls temporary

Madison, Wis. Third Wave Technologies Inc. reported a loss of $4.4 million on revenues of $7.1 million for the quarter that ended March 31, attributing the shortfall to the timing of large orders and slow sales of a line of reagents. Third Wave makes clinical molecular diagnostic products, ...

Transition continues to impact Third Wave financials

Madison, Wis. -- Third Wave Technologies , a provider of molecular diagnostics solutions, reported losses in the second quarter in line with market expectations. Third Wave reported total revenue of $5.8 million and a net loss of $5.5 million, or 13 cents per diluted share, for the quarter en...

Third Wave appoints new chairman

Madison, Wis., - Third Wave Technologies Inc., a developer and provider of molecular diagnostics applications, has elected David A. Thompson chairman of the company's board of directors, replacing company founder Lance Fors, who stepped down as part of the business's planned transition. Thom...

Third Wave receives FDA clearance of pharmacogenetic test

Madison, Wis. -- Third Wave Technologies Inc. on Monday announced that the U.S. Food and Drug Administration (FDA) has cleared the company's Invader UGT1A1 Molecular Assay for in vitro diagnostic use. It is the first pharmacogenetic test to be approved by the FDA for use as a companion diag...

Third Wave wins patent lawsuit against California firm

Madison, Wis. - Third Wave Technologies , a developer and marketer of molecular diagnostics products, announced on Thursday that it has won a patent infringement lawsuit against Stratagene Corp. , a life sciences developer based in La Jolla, Calif. The decision, which was passed by a federal...

Third Wave sued by one firm; gets injunction against another

Madison, Wis. -- Third Wave Technologies Inc. , a developer of molecular diagnostics for a variety of DNA and RNA analysis applications, is being sued by Belgium-based Innogenetics N.V. , which alleges infringement of its hepatitis C virus patents. Meanwhile, in a separate case, Third Wave has ...

Third Wave files patent suits against Digene, Chiron and Bayer

Madison, Wis. -- Third Wave Technologies Inc. has filed suit against three companies, seeking rulings regarding its right to sell two products, the company announced on Tuesday. The suits were filed in federal court in Madison. The company last Friday filed suit against Digene Corp., seeki...

Third Wave Reports Third-Quarter Financial Results

Madison, Wis. Third Wave Technologies Inc. has reported financial results for the third quarter ended Sept. 30, 2005. Third Wave reported total revenue of $5.2 million and a net loss of $7.4 million for the quarter ended Sept. 30, 2005, compared to total revenue of $10.5 million and net incom...

Third Wave CEO steps aside as company departs research market

Madison, Wis. At Third Wave Technologies, former vice president Kevin Conroy is stepping into the shoes of president and CEO. John Puisis, who was CEO since mid-2004 and previously held other executive roles at the company, has resigned. "I came to Third Wave and stayed for a specific purpose...

Third Wave wins triple damages in patent case

A federal judge has tripled Third Wave Technologies ' compensation in a patent lawsuit with rival Stratagene to $15.9 million plus legal fees. Stratagene is proceeding with its appeal. The lawsuit was decided in September after the judge found that Stratagene willfully infringed on two patent...

Stratagene sets aside $21M to pay Third Wave pending appeal

Stratagene Corporation has posted a $21 million bond to pay damages and legal fees to Madison-based rival Third Wave Technologies in a patent case, pending appeal. Third Wave and Stratagene have been battling since late 2004 over which company has the right to commercialize certain molecular...

Third Wave shuffles finance, sales management

Madison, Wis. Third Wave Technologies is appointing more new top management in the wake of its CEO transition, according to a press release. Maneesh Arora, 37, will become CFO after the firm's next annual report is filed. Arora has held senior positions in marketing and operations for the c...

Third Wave licenses Innogenetics tech to settle lawsuit

Madison, Wis. Third Wave Technologies has settled with a Belgian company that sued last September over genotyping patents. Third Wave will license hepatitis C virus genotyping technology from Innogenetics, for undisclosed financial terms. The two companies' relationship goes back further. In ...

Third Wave agrees to drop Chiron, Bayer patent lawsuits

Madison, Wis. Third Wave Technologies Inc. said it has reached an agreement with Chiron Corp., Bayer Corp., and Bayer HealthCare, LLC, to dismiss Third Wave's patent lawsuit. Third Wave said that no licenses or payments were made and did not disclose other terms of the agreement. This le...

Third Wave posts $22 million loss, stock rises

Madison, Wis. A decline in research revenue led Third Wave Technologies to a loss of $22.3 million in 2005, or 54 cents a share, but because the loss was expected share price rose slightly in light trading. As a company in transition, Third Wave expected something of a rough patch. It has a...

Third Wave says patent extends IP reach

Madison, Wis. Third Wave Technologies said on Tuesday that a patent it has just been granted will significantly increase the value of its intellecual property in the U.S. The patent covers a combination of Third Wave's Invader line of genetic analysis products with a type of chain reaction ...

Third Wave announces two senior management appointments

Madison, Wis. — Third Wave Technologies, Inc. has added two executives to its senior management team, including an attorney that helped litigate Third Wave's successful patent infringement suit against Stratagene Corp. The company also announced that it would host a conference call on ...

Third Wave reports clinical growth, continued loss

Madison, Wis. Higher revenue from its clinical molecular diagnostic products could not prevent Third Wave Technologies, Inc. from reporting a loss for the quarter ending March 31, 2006. Third Wave reported total revenues of $7.9 million and a net loss of $4.4 million, or ($0.11) a diluted s...
Other TagsResortCialisDiscloseDistributionEstimatedLeasingManufacturerManufacturer
(Date:12/14/2009)... -- MODA Technology Partners, a global software company ... testing for the Pharmaceutical industry, today announced the ... generation mobile data acquisition platform. The latest release ... their regulated manufacturing processes. ,, MODA 3.0 ... Fully-Configurable Test Methods: Each test method in ...
(Date:12/13/2009)... have resolved a question about how a popular ... using biosensors that reveal previously hidden components of ... delusions and hallucinations characterize the illness, people with ... information in a particular order, difficulties that interfere ... function well, said Lee Schroeder, a student in ...
(Date:12/13/2009)... 2009Researchers at The Scripps Research Institute have solved ... from an ancient family of enzymes can have ... addition to providing guidance for understanding other molecules ... underpinning for the protein,s possible use for combating ... research was published in the December 13, 2009 ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2New biosensors reveal workings of anti-psychotic drugs in the living brain 2Scripps Research scientists crack mystery of protein's dual function 2Scripps Research scientists crack mystery of protein's dual function 3Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 1Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 2Access Pharmaceuticals to Present at the Rodman 26 Renshaw Annual Healthcare Conference 13766 3LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 1LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 2LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 3LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 4LIVALO 28R 29 Demonstrates Sustained Long Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia 55843 5Thoratec Presentation at Baird Conference to be Webcast 13764 1
(Date:12/15/2009)... Massage, and Medical tables announces its partnership with Contour Table ... to ease pressure felt while laying face down during massage. ... ... December 15, 2009 -- OAKWORKS®, Inc., the premier U.S. manufacturer ... of the Utopian Massage Table with patent pending ABC System, ...
(Date:12/15/2009)... the Dec. 15 issue of the Journal of ... obese increases the risk for developing obstructive sleep apnea ... , Results indicate that the risk of OSA ... increased 3.5 fold with each standard-deviation increase in body ... did not significantly increase with increasing BMI among younger ...
(Date:12/14/2009)... particles carry oxygen, drugs, and more… , ... ... Santa Barbara, in collaboration with scientists at University of Michigan, ... key functions of natural red blood cells, including softness, flexibility, ... , ,The primary function of natural red blood cells is ...
(Date:12/14/2009)... Dec. 14 Heska Corporation (Nasdaq: ... a leading provider of veterinary diagnostic and ... installation of the Company,s new DRI-CHEM® 7000 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving ... multi-patient clinical chemistry analyzer available to the ...
(Date:12/14/2009)... 14 Tough Enough To Wear Pink(TM) (TETWP), ... celebrated its fifth anniversary at the signature Tough ... National Finals Rodeo (Wrangler NFR) in Las Vegas. ... rodeo cowboys, the support of the western industry ... crowd sported pink shirts, hats, bracelets and more. ...
Breaking Medicine News(10 mins):Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 2Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 3Health News:Wellness Equipment Manufacturer Announces Revolutionary New Adjustable Breast Comfort System Available on Utopian Portable Massage Table 4Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:Synthetic Red Blood Cells Developed 2Health News:Synthetic Red Blood Cells Developed 3Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4
Other Contentsbranchialyouryouryouryouryouryouryouryouryourodorodorodorodorbreastfeedingbreastfeedingbreastfeedingbreastsbreastsmothersmothersmothersmothersmothersmotherssoundssoundssoundssoundssoundsdifficultiesdifficultiesdifficultiesdifficultiesdifficultiesdifficultiesdifficultiesdifficulties